Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

"Research on sexual outcomes in prostate cancer survivors has focused on the restoration of erections after treatment," notes a new peer-reviewed article by William Kinnaird and others. "The aim ...

Getting your prostate removed can seem daunting, and recovery can involve coping with some temporary but significant changes to your urinary, sexual, and mental health. However, the five-year survival ...

Early-onset prostate cancer: A time series analysis of age-stratified trends. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not include a full ...

Current guidelines for clinically localized prostate cancer offer a wide range of management options, from active surveillance to surgery and radiation therapy (RT). Treatment selection depends on ...